Merck, IBM, Walmart and KPMG to pilot blockchain pharmaceutical supply chain system
The four companies are collaborating under a program that stems from a law that Congress passed in 2013 to develop an electronic pharmaceutical tracking system.
The four companies are collaborating under a program that stems from a law that Congress passed in 2013 to develop an electronic pharmaceutical tracking system.
The KEYNOTE-119 study failed to show a survival benefit in TNBC patients. The news comes two months after the FDA gave accelerated approval to a rival, Roche's Tecentriq.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company said it had shared data from the Phase III study with the FDA. However, per FDA regulations, there is a risk that the accelerated approval for hepatocellular carcinoma could be withdrawn.
The balance of power in the anti-PD-L1 therapy duel has once again shifted with a first-line therapy win by Keytruda for non-small cell lung cancer
Big pharma has been in the news for all the wrong reasons lately, and that includes Merck that had its own bad news to share on the eve of the Labor Day weekend.